OTCMKTS:EKTAY

Elekta (EKTAY) Stock Price, News & Analysis

Elekta logo
$6.21 0.00 (0.00%)
As of 11/16/2026

About Elekta Stock (OTCMKTS:EKTAY)

Advanced

Key Stats

Today's Range
$6.21
▼
$6.21
50-Day Range
$5.02
▼
$6.23
52-Week Range
$4.35
▼
$6.93
Volume
20 shs
Average Volume
888 shs
Market Capitalization
$2.29 billion
P/E Ratio
N/A
Dividend Yield
1.93%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Elekta is a Swedish medical technology company that develops equipment and software for radiation therapy and other treatments used in cancer care and neurosurgery. Founded in 1972 by neurosurgeon Lars Leksell, the company builds on his work in stereotactic radiosurgery.

Its offerings include linear accelerators for external-beam radiation therapy, systems for stereotactic radiosurgery and brachytherapy, and software that helps healthcare providers plan and manage treatment. Elekta’s technologies are used by hospitals and clinics to deliver care for cancer and certain neurological conditions.

The company serves healthcare providers in markets around the world. Its work spans equipment, treatment-planning tools, and clinical information systems designed to support radiation oncology services.

AI Generated. May Contain Errors.

Elekta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

EKTAY MarketRank™: 
1.40487609912 of 5 stars

Elekta scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elekta has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Elekta has received no research coverage in the past 90 days.

  • Read more about Elekta's stock forecast and price target.
  • Earnings Growth

    Earnings for Elekta are expected to grow by 9.30% in the coming year, from $0.43 to $0.47 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elekta is 21.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elekta is 21.43, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.76.

  • Price to Book Value per Share Ratio

    Elekta has a P/B Ratio of 3.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Elekta's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Elekta has been sold short.
  • Short Interest Ratio / Days to Cover

    Elekta has a short interest ratio ("days to cover") of 0.26, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Elekta pays a meaningful dividend of 1.99%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Elekta does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Elekta will have a dividend payout ratio of 25.53% next year. This indicates that Elekta will be able to sustain or increase its dividend.

  • Read more about Elekta's dividend.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Elekta this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Elekta insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    41.28% of the stock of Elekta is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Elekta has minimal institutional ownership at this time.

  • Read more about Elekta's insider trading history.
Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EKTAY Stock News Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
See More Headlines

EKTAY Stock Analysis - Frequently Asked Questions

Elekta's stock was trading at $6.1085 at the beginning of the year. Since then, EKTAY stock has increased by 1.7% and is now trading at $6.2140.

Elekta AB (OTCMKTS:EKTAY) announced its quarterly earnings results on Thursday, August, 27th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $372.30 million for the quarter. Elekta had a negative net margin of 2.38% and a positive trailing twelve-month return on equity of 13.47%.

Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elekta investors own include Check Point Software Technologies (CHKP), Medtronic (MDT), Minerals Technologies (MTX), American Battery Technology (ABML), Adidas (ADDYY), Adyen (ADYEY) and Allianz (ALV).

Company Calendar

Last Earnings
8/27/2026
Today
11/17/2026
Next Earnings (Estimated)
11/25/2026
Fiscal Year End
4/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:EKTAY
CIK
1451160
Employees
4,102
Year Founded
1972

Profitability

EPS (Trailing Twelve Months)
($0.12)
Trailing P/E Ratio
21.43
Forward P/E Ratio
13.22
P/E Growth
N/A
Net Income
-$55.38 million
Net Margins
-2.38%
Pretax Margin
0.40%
Return on Equity
13.47%
Return on Assets
3.84%

Debt

Debt-to-Equity Ratio
0.45
Current Ratio
0.86
Quick Ratio
0.62

Sales & Book Value

Annual Sales
$1.78 billion
Price / Sales
1.29
Cash Flow
$0.63 per share
Price / Cash Flow
9.89
Book Value
$2.07 per share
Price / Book
3.00

Miscellaneous

Outstanding Shares
368,590,000
Free Float
216,435,000
Market Cap
$2.29 billion
Optionable
Not Optionable
Beta
1.01

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:EKTAY) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners